BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 23242053)

  • 1. 18F-FDG PET/CT imaging of extensive systemic sarcoidosis with epididymal involvement.
    Aga F; Yamamoto Y; Tanaka K; Ono Y; Dobashi H; Nishiyama Y
    Clin Nucl Med; 2013 Jan; 38(1):63-4. PubMed ID: 23242053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ocular sarcoidosis: does (18)F-FDG PET/CT have any role?
    Jung RS; Mittal BR; Maturu NV; Kumar R; Bhattacharya A; Gupta D
    Clin Nucl Med; 2014 May; 39(5):464-6. PubMed ID: 24662648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of heparin loading during an 18F-FDG PET/CT examination to search for cardiac sarcoidosis activity.
    Ito K; Morooka M; Okazaki O; Minaminoto R; Kubota K; Hiroe M
    Clin Nucl Med; 2013 Feb; 38(2):128-30. PubMed ID: 23334129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atypical Presentation of Sarcoidosis on ¹⁸F-FDG PET/CT.
    Jolepalem P; McLean KZ; Wong CY
    J Nucl Med Technol; 2014 Jun; 42(2):114-5. PubMed ID: 24627413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The utility of 18F-FDG PET/CT for diagnosis and adjustment of therapy in patients with active chronic sarcoidosis.
    Sobic-Saranovic D; Grozdic I; Videnovic-Ivanov J; Vucinic-Mihailovic V; Artiko V; Saranovic D; Djuric-Stefanovic A; Masulovic D; Odalovic S; Ilic-Dudvarski A; Popevic S; Pavlovic S; Obradovic V
    J Nucl Med; 2012 Oct; 53(10):1543-9. PubMed ID: 22879080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MRI and FDG PET/CT imaging manifestations of cardiac sarcoidosis.
    Lu Y; Sweiss NJ
    Clin Nucl Med; 2015 Dec; 40(12):973-4. PubMed ID: 26544904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The scar sign: a useful finding on FDG PET/CT to distinguish sarcoidosis from other causes of lymphadenopathy.
    Lu SJ; Lee VK; Loo SW
    Clin Nucl Med; 2013 Mar; 38(3):205-8. PubMed ID: 23354040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Responsiveness of FDG PET/CT to treatment of patients with active chronic sarcoidosis.
    Sobic-Saranovic DP; Grozdic IT; Videnovic-Ivanov J; Vucinic-Mihailovic V; Artiko VM; Saranovic DZ; Pavlovic SV; Obradovic VB
    Clin Nucl Med; 2013 Jul; 38(7):516-21. PubMed ID: 23486337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 18F-FDG PET/CT detects systemic involvement in sarcoidosis.
    Ambrosini V; Fasano L; Zompatori M; Nanni C; Allegri V; Nava S; Fanti S
    Eur J Nucl Med Mol Imaging; 2011 Nov; 38(11):2102. PubMed ID: 21547600
    [No Abstract]   [Full Text] [Related]  

  • 10. Impact of [18F]-fluorodeoxyglucose ([18F]-FDG) imaging in sarcoidosis: unsuspected neurosarcoidosis discovered by [18F]-FDG PET and early metabolic response to corticosteroid therapy.
    Aide N; Benayoun M; Kerrou K; Khalil A; Cadranel J; Talbot JN
    Br J Radiol; 2007 Mar; 80(951):e67-71. PubMed ID: 17548505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. F-18 fluorodeoxyglucose and F-18 fluorothymidine positron emission tomography/computed tomography imaging in a case of neurosarcoidosis.
    Kim SK; Im HJ; Kim W; Kim TS; Hwangbo B; Kim HJ
    Clin Nucl Med; 2010 Feb; 35(2):67-70. PubMed ID: 20090446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. (18)F-FDG PET/CT for the assessment of disease extension and activity in patients with sarcoidosis: results of a preliminary prospective study.
    Ambrosini V; Zompatori M; Fasano L; Nanni C; Nava S; Rubello D; Fanti S
    Clin Nucl Med; 2013 Apr; 38(4):e171-7. PubMed ID: 23429384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dramatic change in 18F-FDG uptake in a sarcoidosis case showing spontaneous recovery.
    Ito K; Miyata Y; Minamimoto R; Kubota K
    Clin Nucl Med; 2014 Apr; 39(4):376-8. PubMed ID: 23640228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sarcoidosis mimicking metastatic gynaecological malignancies: a diagnostic and therapeutic challenge?
    Mapelli P; Mangili G; Picchio M; Rabaiotti E; Gianolli L; Messa C; Candiani M
    Rev Esp Med Nucl Imagen Mol; 2013; 32(5):314-7. PubMed ID: 23270913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of integrated FDG-PET/CT in sarcoidosis.
    Krüger S; Buck AK; Mottaghy FM; Pauls S; Schelzig H; Hombach V; Reske SN
    Clin Imaging; 2008; 32(4):269-73. PubMed ID: 18603181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pancreatic involvement detected with (18)F-FDG PET/CT in disseminated sarcoidosis.
    Delgado-Bolton RC; Arias Navalón JA; Rodríguez Alfonso B; Delgado-Bolton AN; Pérez-Castejón MJ; Sánchez-Escribano R; Cabrera Martín MN; Lapeña Gutiérrez L; Carreras Delgado JL
    Rev Esp Med Nucl; 2011; 30(1):29-32. PubMed ID: 20638156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymphomatous involvement of epididymis: detection and response assessment with (18)F-FDG PET/CT.
    Dhull VS; Sharma P; Singla S; Khangembam BC; Bal C; Kumar R
    Clin Nucl Med; 2013 Jun; 38(6):e271-2. PubMed ID: 23510888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extent of disease activity assessed by 18F-FDG PET/CT in a Dutch sarcoidosis population.
    Cremers JP; Van Kroonenburgh MJ; Mostard RL; Vöö SA; Wijnen PA; Koek GH; Drent M
    Sarcoidosis Vasc Diffuse Lung Dis; 2014 Apr; 31(1):37-45. PubMed ID: 24751452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sarcoidlike reaction of neoplasia causing hypermetabolic thoracic adenopathy in setting of extrathoracic malignancy: report of two cases and a review of the differential diagnostic considerations.
    Craun JB; Banks KP; Clemenshaw MN; Moren RW
    J Nucl Med Technol; 2012 Dec; 40(4):231-5. PubMed ID: 23015478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. F-18 FDG PET/CT in the diagnosis of a rare case of neurosarcoidosis in a patient with diabetes insipidus.
    Asabella AN; Gatti P; Notaristefano A; Iuele F; Altini C; Rubini G
    Clin Nucl Med; 2011 Sep; 36(9):795-7. PubMed ID: 21825853
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.